Galanin antagonist
CA 2109503 A1 · Owner: Lindskog, Stefan · Inventors: Wiesenfeld-Hallin, Zsuzsanna; Hokfelt, Tomas; Ahren, Bo
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
A galanin antagonist which is a galanin receptor ligand is described. Further, new peptides Galanin(1-12)-Pro-Substance P(5-11) Galanin(1-12)-Pro-Bradykinin(2-9), Galanin(1-12)-Pro-Pro-Pro-(Leu5-Enkephalin(5-1)) Galanin(1-12)-Pro-Lys(.epsilon.-NH-)Pro-(Leu5-Enkephalin(5-1)) and functional analogues and functional derivates thereof which exhibit substantially the same galanin antagonistic effect as said peptides are disclosed. Use of the galanin antagonist, a pharmaceutical preparation comprising it and a method of treating a disorder in a mammal which depends on the physiological function of galanin at the galanin receptor are also included.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed May 14, 1992. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended May 14, 2012.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by May 14, 2014.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.